Bioter S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 0.091 million compared to EUR 0.096 million a year ago. Net loss was EUR 5.1 million compared to EUR 3.7 million a year ago.

Basic loss per share from continuing operations was EUR 0.3049.